The move would onshore production of its rare disease products at an existing facility in Frederick and build a clinical research drug factory in Gaithersburg.
Categories:
Related Post
Chicago Fire FC unveils renderings for $650M stadium
The venue, announced in early June, will be entirely privately financed by the club’s owner.
CSL breaks ground on $1.5B Illinois immunoglobulin plant expansion
The Kanakee project builds on the biopharma company’s efforts to increase its U.S. footprint, where…
USG to invest $1.2B in Texas factory
The project will create nearly 200 jobs and expand the gypsum products manufacturer’s footprint to…